Fate Therapeutics' GAAP loss for 2020 was $173.387 million, up 76.7% from $98.149 million the previous year. Revenue increased 2.9-fold to $31.434 million from $10.68 million a year earlier.
Fate Therapeutics' GAAP loss for 2020 was $173.387 million, up 76.7% from $98.149 million the previous year. Revenue increased 2.9-fold to $31.434 million from $10.68 million a year earlier. 
ir.fatetherapeutics.com
English (US) 